We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNONW icon
326
Tenon Medical Inc Warrant
TNONW
$1.49K
$10.5K ﹤0.01%
178,000
-1,602,000
-90% -$75K
IVDAW icon
327
Iveda Solutions Warrant
IVDAW
$47.8K
$10.2K ﹤0.01%
145,000
– –
BNCWW
328
CEA Industries Inc Warrant
BNCWW
$9.1K ﹤0.01%
700,000
– –
NEXRW
329
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$4.01K ﹤0.01%
68,681
-412,088
-86% -$33K
ACONW icon
330
Aclarion Warrant
ACONW
$49.4K
$1.2K ﹤0.01%
34,375
-515,625
-94% -$19.5K
KTTAW icon
331
Pasithea Therapeutics Warrants
KTTAW
$5.69K
$615 ﹤0.01%
50,000
-950,000
-95% -$13.1K
CINGW icon
332
Cingulate Inc Warrants
CINGW
$33.2K
$433 ﹤0.01%
20,500
-389,500
-95% -$7.63K
EDBLW
333
Edible Garden AG Warrant
EDBLW
$65.4K
$408 ﹤0.01%
26,666
-773,334
-97% -$12.1K
AREBW
334
DELISTED
American Rebel Holdings Warrants
AREBW
$289 ﹤0.01%
193
-4,626
-96% -$4.27K
DRMAW icon
335
Dermata Therapeutics Warrant
DRMAW
$12.4K
$193 ﹤0.01%
20,312
-304,688
-94% -$4.69K
BRSHW
336
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$183 ﹤0.01%
24,038
-576,924
-96% -$5.42K
AGRIW
337
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$106 ﹤0.01%
12,000
-588,000
-98% -$4.94K
ADIL
338
Adial Pharmaceuticals
ADIL
$8.71M
– –
-6,360
Closed -$296K
ADXN
339
Addex Therapeutics
ADXN
$7.34M
– –
-43,000
Closed -$260K
AIMDW icon
340
Ainos Warrants
AIMDW
$80.7K
– –
-25,000
Closed -$1.05K
APCX
341
DELISTED
AppTech Payments
APCX
– –
-100,000
Closed -$199K
APVO icon
342
Aptevo Therapeutics
APVO
$5.21M
– –
0
– -$11.1K
AQST icon
343
Aquestive Therapeutics
AQST
$494M
– –
-3,924,000
Closed -$7.93M
AREB
344
DELISTED
American Rebel
AREB
– –
0
– -$135K
ASRT
345
DELISTED
Assertio
ASRT
– –
-386,667
Closed -$6.21M
ATXS
346
DELISTED
Astria Therapeutics
ATXS
– –
-1,578,000
Closed -$12.1M
BKYI
347
BIO-key International
BKYI
$4.38M
– –
-6,533
Closed -$196K
BLTE
348
Belite Bio
BLTE
$6.54B
– –
-36,000
Closed -$1.65M
STEX
349
Streamex Corp
STEX
$83M
– –
-560,000
Closed -$2.66M
CBRL icon
350
Cracker Barrel
CBRL
$1.29B
– –
-50,000
Closed -$3.85M
12 13
14
15 16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.